clonoSEQ testing for patients with MCL is currently available for clinical use as a laboratory-developed test performed at ...

In a statistical analysis, Brukinsa resulted in fewer cases of disease progression or death and resulted in lower overall healthcare costs than Imbruvica in patients with chronic lymphocytic leukemia.

Taking a patient's immune cells and targeting their cancer with them, which is called CAR T cell therapy, is showing promise ...

Today’s recommendation is an important advance within the mantle cell lymphoma first-line treatment ... patients with multiple B-cell blood cancers, including CLL, MCL and diffuse large B-cell ...

EMA committee recommends approval of AstraZeneca’s Calquence plus chemoimmunotherapy to treat adult patients with mantle cell lymphoma: Cambridge, UK Tuesday, April 1, 2025, 17: ...

They grow slowly, starting in your blood and bone marrow (CLL) or spleen (SLL ... or bone marrow. Mantle cell lymphoma grows slowly but can be hard to treat. In this type of lymphoma, small ...

SGN-CD19A demonstrated anti-tumor activity across a panel of cell lines derived from multiple B-cell lymphoma and leukemia subtypes ... lymphoid tissue; MCL: Mantle cell lymphoma; MTD: Maximum ...

Axi-cel, tisa-cel, and brexu-cel were found comparable to other cellular therapy experiences for patients with B-cell ...

For many decades, the foundations of cancer treatment have been surgery, chemotherapy, and radiation therapy. But, in recent years, a newer therapy in the form of immunotherapy has emerged, ...